文献速递肝病

活检证实的酒精相关肝病死亡率:全国人群队列研究

Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients.
PubMed 文献 · Gut · 2020-03-27

ALD患者5年累积死亡率为40.9%,对照组为5.8%;调整后总死亡风险显著升高(aHR=4.70,95%CI 4.35-5.08),肝相关死亡占全部死亡的43%(aHR=167.6,95%CI 101.7-276.3)。无肝硬化ALD患者死亡风险亦显著升高。

要点

  • 活检证实的ALD患者总死亡风险约为普通人群的近5倍(aHR=4.70)。
  • 肝相关死亡占全部死亡的43%,风险极高(aHR=167.6)。
  • 无肝硬化的ALD患者死亡风险也显著增加,需加强管理。

核心结论

  • 活检证实的ALD患者死亡风险约为普通人群的近5倍。
  • 无肝硬化的ALD患者死亡风险亦显著增加,需提高管理警惕性。

研究设计与样本

  • 基于瑞典全国人群的队列研究,纳入3453例有ALD ICD诊断且接受肝活检的个体(1969-2017年)。
  • 采用Cox回归调整相关混杂因素估计风险比。

主要发现

  • 中位诊断年龄58岁,65%为男性,52%基线有肝硬化。
  • ALD患者5年累积死亡率为40.9%,对照组为5.8%。
  • 总死亡风险显著升高(aHR=4.70,95%CI 4.35-5.08)。
  • 肝相关死亡占全部死亡的43%(aHR=167.6,95%CI 101.7-276.3)。
  • 无肝硬化ALD患者死亡风险亦显著升高;随访≥10年后风险仍持续(aHR=2.74,95%CI 2.37-3.16)。

临床怎么用

  • 对活检证实的ALD患者应认识到其死亡风险近5倍于普通人群,需积极管理。
  • 无肝硬化的ALD患者同样存在显著死亡风险,不应低估其病情。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with alcohol-related liver disease (ALD) are at increased risk of death, but studies have rarely investigated the significance of histological severity or estimated relative risks compared with a general population. We examined mortality in a nationwide cohort of biopsy-proven ALD. DESIGN: Population-based cohort study in Sweden comparing 3453 individuals with an International Classification of Disease (ICD) code for ALD and a liver biopsy from 1969 to 2017 with 16 535 matched general population individuals. Swedish national registers were used to ascertain overall and disease-specific mortality, starting follow-up at the latest of first ICD diagnosis or liver biopsy plus 3 months. Cox regression adjusted for relevant confounders was used to estimate HRs in ALD and histopathological subgroups. RESULTS: Median age at diagnosis was 58 years, 65% were men and 52% had cirrhosis at baseline. Five-year cumulative mortality was 40.9% in patients with ALD compared with 5.8% in reference individuals. The risk for overall mortality was significantly increased (adjusted HR (aHR)=4.70, 95% CI 4.35 to 5.08). The risk of liver-related death was particularly high (43% of all deaths, aHR=167.6, 95% CI 101.7 to 276.3). Mortality was significantly increased also in patients with ALD without cirrhosis and was highest in the first year after baseline but persisted after ≥10 years of follow-up (aHR=2.74, 95% CI 2.37 to 3.16). CONCLUSION: Individuals with biopsy-proven ALD have a near fivefold increased risk of death compared with the general population. Individuals with ALD without cirrhosis were also at increased risk of death, reaffirming the need to increase vigilance in the management of these individuals.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Hagström H, Thiele M, Roelstraete B, et al. Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients. Gut. 2020. PMID: 32220902. doi:10.1136/gutjnl-2019-320446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。